Inhibition of Henipavirus infection by RNA interference

[1]  S. Elbashir,et al.  Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). , 2008, Antiviral research.

[2]  G. Kellogg,et al.  Molecular Determinants of Antiviral Potency of Paramyxovirus Entry Inhibitors , 2007, Journal of Virology.

[3]  J. A. Comer,et al.  Risk of Nosocomial Transmission of Nipah Virus in a Bangladesh Hospital , 2007, Infection Control & Hospital Epidemiology.

[4]  M. Fornabaio,et al.  Inhibition of Hendra Virus Fusion , 2006, Journal of Virology.

[5]  C. Broder,et al.  Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.

[6]  C. Basler,et al.  Mutation of YMYL in the Nipah Virus Matrix Protein Abrogates Budding and Alters Subcellular Localization , 2006, Journal of Virology.

[7]  H. Contamin,et al.  Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection , 2006, Antimicrobial Agents and Chemotherapy.

[8]  Oscar A. Negrete,et al.  Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus , 2006, PLoS pathogens.

[9]  S. Hammond.  Dicing and slicing , 2005, FEBS letters.

[10]  J. A. Comer,et al.  Genetic Characterization of Nipah Virus, Bangladesh, 2004 , 2005, Emerging infectious diseases.

[11]  Oscar A. Negrete,et al.  EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus , 2005, Nature.

[12]  B. Eaton,et al.  RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription , 2005, Archives of Virology.

[13]  Sangdun Choi,et al.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.

[14]  J. Stone,et al.  Poliovirus Escape from RNA Interference: Short Interfering RNA-Target Recognition and Implications for Therapeutic Approaches , 2005, Journal of Virology.

[15]  R. Kirkman,et al.  Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. , 2004, Virology.

[16]  C. Horvath,et al.  Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. , 2004, Viral immunology.

[17]  Wei-zao Chen,et al.  RNA Interference Targeting VP1 Inhibits Foot-and-Mouth Disease Virus Replication in BHK-21 Cells and Suckling Mice , 2004, Journal of Virology.

[18]  A. García-Sastre,et al.  Nipah Virus V and W Proteins Have a Common STAT1-Binding Domain yet Inhibit STAT1 Activation from the Cytoplasmic and Nuclear Compartments, Respectively , 2004, Journal of Virology.

[19]  S. Barik.  Control of nonsegmented negative-strand RNA virus replication by siRNA. , 2004, Virus research.

[20]  B. Schaffhausen,et al.  Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase☆ , 2004, Virology.

[21]  W. Bellini,et al.  Nipah virus conforms to the rule of six in a minigenome replication assay. , 2004, The Journal of general virology.

[22]  H. Giladi,et al.  Small interfering RNA inhibits hepatitis B virus replication in mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  N. Ito,et al.  Improved Recovery of Rabies Virus from Cloned cDNA Using a Vaccinia Virus‐Free Reverse Genetics System , 2003, Microbiology and immunology.

[24]  R. Amado,et al.  Gene therapy for HIV/AIDS: the potential for a new therapeutic regimen , 2003, The journal of gene medicine.

[25]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[26]  Mamoru Watanabe,et al.  Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs , 2003, EMBO reports.

[27]  H. Field,et al.  Managing emerging diseases borne by fruit bats (flying foxes), with particular reference to henipaviruses and Australian bat lyssavirus , 2003, Journal of applied microbiology.

[28]  Y. Guan,et al.  Prophylactic and Therapeutic Effects of Small Interfering Rna Targeting Sars-Coronavirus , 2003, Antiviral therapy.

[29]  B. Eaton,et al.  Sites of phosphorylation of P and V proteins from Hendra and Nipah viruses: newly emerged members of Paramyxoviridae. , 2003, Virus research.

[30]  G. Neumann,et al.  A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? , 2002, The Journal of general virology.

[31]  J. Oxford,et al.  The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. , 2002, Antiviral research.

[32]  J. Lieberman,et al.  siRNA-directed inhibition of HIV-1 infection , 2002, Nature Medicine.

[33]  J. Oxford,et al.  Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. , 2002, Antiviral research.

[34]  A. Monto,et al.  Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. , 2002, Antiviral research.

[35]  K. Chua,et al.  Treatment of acute Nipah encephalitis with ribavirin , 2001, Annals of neurology.

[36]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[37]  H. Field,et al.  Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. , 2001, Emerging infectious diseases.

[38]  P. Zipperlen,et al.  Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans , 2000, Genome Biology.

[39]  J. McKimm-Breschkin,et al.  Resistance of influenza viruses to neuraminidase inhibitors--a review. , 2000, Antiviral research.

[40]  W. Bellini,et al.  Molecular characterization of Nipah virus, a newly emergent paramyxovirus. , 2000, Virology.

[41]  G. Fattovich,et al.  Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage , 2000, Hepatology.

[42]  Adeeba Kamarulzaman,et al.  Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia , 1999, The Lancet.

[43]  B. Eaton,et al.  Animals Infection in Humans, Horses, and Other Family, Which Causes Lethal Paramyxoviridae a Novel P/v/c Gene in a New Member of The , 1998 .

[44]  D. Paterson,et al.  Fatal encephalitis due to novel paramyxovirus transmitted from horses , 1997, The Lancet.

[45]  H. Field,et al.  Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. , 1996, Emerging infectious diseases.

[46]  A. Hyatt,et al.  Ultrastructure of equine morbillivirus. , 1996, Virus research.

[47]  A. Gould,et al.  A morbillivirus that caused fatal disease in horses and humans. , 1995, Science.

[48]  P. Rota,et al.  Effects of single amino acid substitutions at the E residue in the conserved GDNE motif of the Nipah virus polymerase (L) protein , 2006, Archives of Virology.

[49]  C. Broder,et al.  Hendra and Nipah viruses: different and dangerous , 2006, Nature Reviews Microbiology.

[50]  J. Epstein,et al.  The emergence of Nipah and Hendra virus: pathogen dynamics across a wildlife-livestock-human continuum. , 2006 .

[51]  H. Field,et al.  Emerging encephalitogenic viruses: lyssaviruses and henipaviruses transmitted by frugivorous bats. , 2004, Archives of virology. Supplementum.

[52]  K. Chua,et al.  The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. , 2001, The Journal of infection.

[53]  Max Sussman,et al.  Topley and Wilson's Microbiology and Microbial infections , 1998 .

[54]  A. Lamb.  Paramyxoviridae : The virus and their replication , 1996 .

[55]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[56]  A. Hyatt,et al.  A novel morbillivirus pneumonia of horses and its transmission to humans. , 1995, Emerging infectious diseases.